C-REACTIVE PROTEIN (CRP) - serum
Specimen: 5 mL
blood in plain tube.
Method: Immunoassay.
Reference Interval: <5 mg/L.
Application: Assessment of acute phase reaction in inflammatory, infective and
neoplastic disorders; monitoring disease activity, particularly in inflammatory arthritis;
monitoring patients after premature rupture of the membranes, for developing infection;
assessment of risk factors for myocardial infarction. Marginally raised CRP has
been demonstrated to be an independent risk factor for coronary artery disease; however,
the applicability of measuring serum CRP for screening in asymptomatic populations
for coronary artery disease risk remains unclear.
Interpretation: Elevation indicates acute phase response or active disease in
chronic inflammatory disorders. CRP is a more sensitive early indicator of an acute
phase response than is the ESR. It also returns towards normal more rapidly with
improvement or resolution of the disease process. The test is less sensitive than
the ESR for some disorders eg ulcerative colitis, SLE. In patients at risk for
myocardial infarction and without other causes of an acute phase response, the presence
of slightly elevated or even high normal CRP indicates a greater risk of myocardial
infarction than previously assessed. This use of CRP requires a special, high sensitivity
assay. See also
ERYTHYROCYTE SEDIMENTATION RATE
and
ACUTE PHASE REACTANTS
.
Reference: Young B et al. Pathology 1991; 23: 118-124.